- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07747831
Powered Impaction and Broaching in Elderly Total Hip Arthroplasty
Demonstrating the Effect of Powered Broaching and Impaction in Direct Anterior Total Hip Arthroplasty. A Multi-centre Comparison of Patients 70 Years and Older
Study Overview
Status
Detailed Description
Preparation of the femoral canal and acetabulum impaction have traditionally been accomplished with the use of a mallet and manual instruments. During manual broaching or impaction, force is transmitted with each mallet strike, which distributes horizontal forces to cortical bone. Excessive force and malalignment of instruments can lead to intraoperative fractures, or unrecognized fractures contributing to early failure of the total hip arthroplasty (THA). This risk can be elevated in direct anterior (DA) THA when exposure is compromised due to the minimally invasiveness of the approach. The advent of powered broaching devices which provide a consistent force and are more ergonomic, now provide an alternative to manual techniques. Despite its proposed benefits, it has yet to achieve widespread adoption.
The study aims to assess whether the use of a powered broaching device (KINCISE2) has an impact on intraoperative or early postoperative femoral or acetabular fractures in patients 70 years or older, when compared to traditional manual techniques in DA THA. Patients will be subgrouped based on femoral/acetabular bone quality/morphology. Secondary outcomes measured will consist of femoral canal fil, femoral version and acetabular cup-floor gap and gait analysis measures via markerless motion capture. Surgical efficiency will be measured via operative time, broaching/impaction time and surgical stress via biometric monitoring. PROMs will be measured via the short form Hip disability and Osteoarthritis Outcome Score (HOOS-Jr). Surgeons can use a standard OR table vs. a specialized traction table (HANA) and may use fluoroscopy or no intraoperative imaging.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jhase Sniderman
- Phone Number: 9029323130
- Email: jhase.sniderman@nshealth.ca
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2K 2M9
- Concordia Joint Replacement Group / Concordia Hospital
-
Contact:
- Trevor Gascoyne
- Phone Number: (204) 926-1200
- Email: tgascoyne@orthoinno.com
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H1C3
- Nova Scotia Health
-
Contact:
- Jhase Sniderman
- Phone Number: 9029323130
- Email: jhasesniderman@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients 70 years or older undergoing total hip replacement
Exclusion Criteria:
- Unable to undergo the informed consent process
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Total Hip Replacement
Standard direct anterior total hip replacement
|
Total hip replacement without automatic impaction and broaching
|
|
Experimental: Total Hip Replacement with KINCISE2
Standard direct anterior total hip replacement with KINCISE2
|
Total hip replacement with the use of an automatic impaction and broaching device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Periprosthetic fracture
Time Frame: 90 days
|
Intraoperative or early postoperative femoral/acetabular fractures in patients 70 years or older, when compared to traditional manual techniques in DA THA.
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gait analysis
Time Frame: 90 days
|
Preoperative and postoperative markerless motion capture at 3 months - gait speed, gait symmetry, cadence, step length, stance-time symmetry and hip flexion extension
|
90 days
|
|
Image based implant positioning
Time Frame: 7 days
|
Measured via femoral canal fill, femoral version, acetabular floor-cup gap on postoperative CT scan
|
7 days
|
|
Surgical efficiency
Time Frame: 1 day
|
Measured via operative time (minutes), broaching time (minutes), impaction time (minutes)
|
1 day
|
|
Surgical stress as measured by heart rate
Time Frame: 1 day
|
Measured via biometric assessment with wearable technology by the surgeon (Heart rate - beats per minute)
|
1 day
|
|
Surgical stress as measured by respiratory rate
Time Frame: 1 day
|
Measured via biometric assessment with wearable technology by the surgeon (respiratory rate - breaths/minute)
|
1 day
|
|
Patient reported outcome measure
Time Frame: 90 days
|
HOOS-JR (Hip Osteoarthritis Outcome Score - Joint Replacement).
Scale is 0-100, with zero the worst possible hip problem and 100 being no hip problem.
|
90 days
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DPS-Joints-2026-009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.